Facial Tightening
Conditions
Interventions
Group A:Half of the face was treated with microfocused ultrasound combined with 633nm red light
Group B:Half of the face was treated with 633nm red light
Sponsors
Shanghai Skin Disease Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Male or female, aged 40-65 years old, who need to receive facial rejuvenation treatment due to facial aging; 2. Fitzpatrick skin type II-IV, with mild to severe facial aging manifestations, such as facial wrinkles, bilateral nasolabial folds, cheek skin laxity; 3. Agree to participate in this study and follow up on time by signing the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those who are pregnant, breastfeeding or planning to become pregnant during the follow-up period; 2. those with pre-existing keloids or proliferative scarring; 3. Those who are undergoing other clinical studies; 4. the presence of other skin diseases on the face that affect the evaluation of efficacy; 5. Those who have received phototherapy or topical epidermal regeneration drugs on the face within 1 month; 6. those who have received hyaluronic acid fillers, botulinum toxin treatment on the face within the previous 6 months or other facial treatments that may affect the evaluation of effectiveness; 7. those with severe systemic dermatologic diseases, medical disorders, coagulation disorders, psychological and psychiatric disorders, and infectious diseases; 8. other conditions that the investigator considers unsuitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GAIS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Wrinkle Score;Pigmentation Score;Adverse reaction assessment;Subject satisfaction; | — |
Countries
China
Contacts
Public Contactxiuli Wang
Shanghai Skin Disease Hospital
Outcome results
None listed